Abstract:Glucokinase (GK) encoded by glucokinase gene (GCK) is the first rate-limiting enzyme in glucose metabolism. The heterozygous inactivating mutations of GCK cause maturity-onset diabetes of the young (GCK-MODY). Unlike other types of diabetes, GCK-MODY is not associated with increased risks of diabetic complications in young patients. However, the long-term effects of mutant GK on lipid profiles and chronic complications in elder patients remain unknown. Herein, we established a knock-in mouse model heterozygeously expressing a novel GCK mutation encoding GK-Q26L that was identified in a Chinese family with early onset diabetes. GK-Q26L mice developed mild early onset diabetes with moderate elevated blood glucose and decreased serum insulin, confirming diabetogenes of GK-Q26L. To determine age- and diet-related diabetic complications and lipid profiles, we have fed the mice with either chow diet or high-fat diet (HFD) for 28, 40, or 60 weeks. We found that, after 28 week of HFD, GK-Q26L alleviated abnormal lipid profiles in plasma and liver, suggesting beneficial effects of GK-Q26L on lipid metabolism. Surprisingly however, those protective effects were disappeared at 40 weeks, and at 60 weeks of HFD, GK-Q26L mice exhibited even more severe abnormal lipid profiles. Consistent with the distinct trends of lipid profiles, HFD-induced kidney injury (increased urinary albumin/creatinine ratio and renal fibrosis) was also alleviated in GK-Q26L mice at 28 weeks of HFD, but aggravated at 60 weeks of HFD. Similar effects on diabetic retinopathy were observed in GK-Q26L mice. These data reveal for the first time that although inactivating GCK mutations have beneficial effects on HFD-induced abnormal lipid metabolism and diabetes related damages of kidney and retina in short-term, it is strongly associated with long-term diabetic nephropathy and retinopathy. This study suggests that more attention should be paid on the long-term chronic complications in elder patients with GCK-MODY. Disclosure Y.Huang: None. Y.Fan: None. X.Li: None. S.Ji: None. S.Chen: None. J.Cui: None. W.Feng: None. H.Shu: None. M.Liu: None. Funding National Natural Science Foundation of China (81830025, 82220108014, 82100865, 81800733, 81900720, 82000796, 82070854); National Key R&D Program of China (2019YFA0802502, 2022YFE0131400); Tianjin Key Medical Discipline Construction Project (TJYXZDXK-030A)

Long term liver specific glucokinase gene defect induced diabetic cardiomyopathy by up regulating NADPH oxidase and down regulating insulin receptor and p-AMPK

Identification of Differentially Expressed Genes and Processes in Myocardial Tissue of Liver-Specific Gck Knockout Mice

Expression Changes Of Mitogen-Actilvated Protelin Kinase Phosphatase-1 (Mkp-1) In Myocardium Of Streptozotocin-Induced Diabetic Rats

1-OR: The Improvement Effects of Glucokinase Loss-of-Function Mutation on Lipid Metabolism

Characterization of the Gene Expression Profile of Heterozygous Liver-Specific Glucokinase Knockout Mice at A Young Age

Cardioprotective effects of acute rosiglitazone treatment

Long-term Renal Changes in the Liver-Specific Glucokinase Knockout Mouse: Implications for Renal Disease in Maturity-Onset Diabetes of the Young 2

Ectopic Overexpression Of Ppar Gamma 2 In The Heart Determines Differences In Hypertrophic Cardiomyopathy After Treatment With Different Thiazolidinediones In A Mouse Model Of Diabetes

Ectopic Overexpression of PPARγ2 in the Heart Determines Differences in Hypertrophic Cardiomyopathy After Treatment With Different Thiazolidinediones in a Mouse Model of Diabetes

Differential expression of genes and changes in glucose metabolism in the liver of liver-specific glucokinase gene knockout mice.

Blunted Cardiac AMPK Response is Associated with Susceptibility to Ischemia/Reperfusion in Male Offspring of Gestational Diabetic Rats.

503-P: Distinct Effects of a Novel GCK-MODY Mutation on Lipid Profiles and Diabetic Complications

Compromised chronic efficacy of a Glucokinase Activator AZD1656 in mouse models for common human GCKR variants

ZP2495 Protects against Myocardial Ischemia/Reperfusion Injury in Diabetic Mice through Improvement of Cardiac Metabolism and Mitochondrial Function: The Possible Involvement of AMPK-FoxO3a Signal Pathway

Abstract 486: Genetic Deletion of Akt2 and AMPK Accentuates Insulin Resistance-Induced Cardiac Contractile Anomalies

Cardiac-Specific Overexpression of HIF-1α Prevents Deterioration of Glycolytic Pathway and Cardiac Remodeling in Streptozotocin-Induced Diabetic Mice

Effects of glucokinase haploinsufficiency on the pancreatic β‐cell mass and function of long‐term high‐fat, high‐sucrose diet‐fed mice

Establishment of Liver Specific Glucokinase Gene Knockout Mice: a New Animal Model for Screening Anti-Diabetic Drugs.

Differential Expression of Genes Associated with the Progression of Renal Disease in the Kidneys of Liver-Specific Glucokinase Gene Knockout Mice

Weighted Gene Co-Expression Network Analysis Identifies ANGPTL4 as a Key Regulator in Diabetic Cardiomyopathy via FAK/SIRT3/ROS Pathway in Cardiomyocyte

Hyperglycemia-Induced Protein Kinase C Β2 Activation Induces Diastolic Cardiac Dysfunction in Diabetic Rats by Impairing Caveolin-3 Expression and Akt/eNOS Signaling